Results 201 to 210 of about 182,037 (304)
Exploring the association between serum vitamins and CAP-defined hepatic steatosis in lean and non-lean adults with NAFLD: A cross-sectional study. [PDF]
Hong C, Jiang L, Xia L.
europepmc +1 more source
Favorable cardiovascular health at young and middle ages and dementia in older age—The CHA study [PDF]
Allen, Norrina B +11 more
core +1 more source
ABSTRACT Background Fatty infiltration, or fatty atrophy, of the abductor digiti minimi (ADM) muscle of the foot is proposed to be associated with entrapment of the first branch of the lateral plantar nerve (i.e., Baxter's neuropathy) as part of plantar heel pain (PHP). However, this association has not been rigorously investigated.
John S. C. Chen +7 more
wiley +1 more source
Comorbidities and Molecular Genetics Status in Familial and Nonfamilial Hypercholesterolemia: A Single-Center Study. [PDF]
Timoshchenko O +6 more
europepmc +1 more source
Exploring the Gut‐Prostate Axis: Microbial Signatures Linked to Prostate Volume and Bladder Function
ABSTRACT Background Benign prostatic hyperplasia (BPH) is a common urologic condition in aging men, often linked to systemic inflammation and metabolic dysfunction. Emerging evidence suggests that the gut microbiome may contribute to prostate health and disease.
Jonathan Surber +12 more
wiley +1 more source
ABSTRACT Background Further work is needed to improve treatment outcomes for prostate cancer (PCa), with the repurposing of the α1‐adrenoreceptor antagonists presenting a potential solution. This feasibility clinical trial presents the first prospective data of the use of an α1‐adrenoreceptor antagonist in men undergoing radiotherapy for PCa.
Liam D. King +8 more
wiley +1 more source
FDG-PET/CT of Achilles Tendon Xanthoma: A Hot Take on Imaging in Familial Hypercholesterolemia. [PDF]
Kramer AI, Brunham LR.
europepmc +1 more source
Lung cancer remains Australia's leading cause of cancer death. With new screening and evolving therapies, equitable access and workforce readiness are essential. This review discusses current and emerging treatments for NSCLC in Australia, clinical trials underway, and future directions in delivering optimal, accessible care nationwide.
Lauren Julia Brown +7 more
wiley +1 more source

